Alnylam Pharmaceuticals, Inc. – 12-02-2026

Manufacturers that fail to comply with the IRA may be subject to various penalties, including civil monetary penalties or a potential excise tax. The impact of the IRA on the pharmaceutical industry is significant and ongoing.

Scroll to Top